133 related articles for article (PubMed ID: 12397068)
1. Localization of the heparin binding exosite of factor IXa.
Yang L; Manithody C; Rezaie AR
J Biol Chem; 2002 Dec; 277(52):50756-60. PubMed ID: 12397068
[TBL] [Abstract][Full Text] [Related]
2. Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding.
Rezaie AR
J Biol Chem; 2000 Feb; 275(5):3320-7. PubMed ID: 10652320
[TBL] [Abstract][Full Text] [Related]
3. Sodium-site in serine protease domain of human coagulation factor IXa: evidence from the crystal structure and molecular dynamics simulations study.
Vadivel K; Schreuder HA; Liesum A; Schmidt AE; Goldsmith G; Bajaj SP
J Thromb Haemost; 2019 Apr; 17(4):574-584. PubMed ID: 30725510
[TBL] [Abstract][Full Text] [Related]
4. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
Schmidt AE; Stewart JE; Mathur A; Krishnaswamy S; Bajaj SP
J Mol Biol; 2005 Jul; 350(1):78-91. PubMed ID: 15913649
[TBL] [Abstract][Full Text] [Related]
5. Contribution of basic residues of the autolysis loop to the substrate and inhibitor specificity of factor IXa.
Yang L; Manithody C; Olson ST; Rezaie AR
J Biol Chem; 2003 Jul; 278(27):25032-8. PubMed ID: 12721300
[TBL] [Abstract][Full Text] [Related]
6. Exosite occupation by heparin enhances the reactivity of blood coagulation factor IXa.
Neuenschwander PF
Biochemistry; 2004 Mar; 43(10):2978-86. PubMed ID: 15005634
[TBL] [Abstract][Full Text] [Related]
7. Contribution of basic residues of the 70-80-loop to heparin binding and anticoagulant function of activated protein C.
Yang L; Manithody C; Rezaie AR
Biochemistry; 2002 May; 41(19):6149-57. PubMed ID: 11994010
[TBL] [Abstract][Full Text] [Related]
8. The factor IXa second epidermal growth factor (EGF2) domain mediates platelet binding and assembly of the factor X activating complex.
Wilkinson FH; Ahmad SS; Walsh PN
J Biol Chem; 2002 Feb; 277(8):5734-41. PubMed ID: 11714704
[TBL] [Abstract][Full Text] [Related]
9. Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease.
Izaguirre G; Aguila S; Qi L; Swanson R; Roth R; Rezaie AR; Gettins PG; Olson ST
J Biol Chem; 2014 Dec; 289(49):34049-64. PubMed ID: 25331949
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.
Johnson DJ; Langdown J; Huntington JA
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):645-50. PubMed ID: 20080729
[TBL] [Abstract][Full Text] [Related]
11. Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding.
Hopfner KP; Lang A; Karcher A; Sichler K; Kopetzki E; Brandstetter H; Huber R; Bode W; Engh RA
Structure; 1999 Aug; 7(8):989-96. PubMed ID: 10467148
[TBL] [Abstract][Full Text] [Related]
12. The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X.
Misenheimer TM; Buyue Y; Sheehan JP
Biochemistry; 2007 Jul; 46(26):7886-95. PubMed ID: 17563121
[TBL] [Abstract][Full Text] [Related]
13. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
Yuan QP; Walke EN; Sheehan JP
Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
[TBL] [Abstract][Full Text] [Related]
14. Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa.
Yang L; Manithody C; Qureshi SH; Rezaie AR
J Biol Chem; 2010 Sep; 285(37):28488-95. PubMed ID: 20628058
[TBL] [Abstract][Full Text] [Related]
15. Residues Tyr253 and Glu255 in strand 3 of beta-sheet C of antithrombin are key determinants of an exosite made accessible by heparin activation to promote rapid inhibition of factors Xa and IXa.
Izaguirre G; Olson ST
J Biol Chem; 2006 May; 281(19):13424-13432. PubMed ID: 16517611
[TBL] [Abstract][Full Text] [Related]
16. Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.
Westmark PR; Tanratana P; Sheehan JP
J Thromb Haemost; 2015 Jun; 13(6):1053-63. PubMed ID: 25851619
[TBL] [Abstract][Full Text] [Related]
17. Physiological fIXa activation involves a cooperative conformational rearrangement of the 99-loop.
Sichler K; Kopetzki E; Huber R; Bode W; Hopfner KP; Brandstetter H
J Biol Chem; 2003 Feb; 278(6):4121-6. PubMed ID: 12444082
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.
Plautz WE; Sekhar Pilli VS; Cooley BC; Chattopadhyay R; Westmark PR; Getz T; Paul D; Bergmeier W; Sheehan JP; Majumder R
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):816-828. PubMed ID: 29419409
[TBL] [Abstract][Full Text] [Related]
19. Residues 88-109 of factor IXa are important for assembly of the factor X activating complex.
Wilkinson FH; London FS; Walsh PN
J Biol Chem; 2002 Feb; 277(8):5725-33. PubMed ID: 11726655
[TBL] [Abstract][Full Text] [Related]
20. Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor.
Neese LL; Wolfe CA; Church FC
Arch Biochem Biophys; 1998 Jul; 355(1):101-8. PubMed ID: 9647672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
